ACP Cautions Against COVID-19 Vaccine Recommendation Changes
American College of Physicians leaders warn that abrupt changes to COVID-19 vaccine recommendations could jeopardize payment coverage and place millions of Americans at risk.
American College of Physicians leaders warn that abrupt changes to COVID-19 vaccine recommendations could jeopardize payment coverage and place millions of Americans at risk.
American College of Physicians leaders warn that abrupt changes to COVID-19 vaccine recommendations could jeopardize payment coverage and place millions of Americans at risk.
Read MoreThe US FDA has approved mepolizumab (Nucala) as an add-on maintenance treatment for adult patients with inadequately controlled COPD and an eosinophilic phenotype.
Read MoreSanofi and Regeneron’s COPD drug candidate itepekimab met its primary endpoint in one phase 3 study but failed in a second trial.
Read MoreModerna’s biologics license application for its flu/COVID combination vaccine candidate for adults aged 50 years and older.
Read MoreTreatment with tezepelumab (Tezspire) can substantially reduce or eliminate oral corticosteroid (OCS) use in adults with OCS-dependent severe asthma, according to new Phase 3 WAYFINDER results presented at ATS 2025.
Read MoreTwo posters presented at ATS 2025 offered data on Rein Therapeutics’ novel peptide LTI-03’s potential clinical value for idiopathic pulmonary fibrosis patients.
Read MoreResults from the BATURA Phase IIIb trial found that albuterol–budesonide (AirSupra) demonstrated a 47% reduction in the risk of severe exacerbations in mild asthma compared with albuterol alone
Read MoreEngineers are testing a capsule that can be packed with multiple medications and release them at designated times throughout the day.
Read MorePresident Trump signed an executive order on Monday to “bring the prices Americans and taxpayers pay for prescription drugs in line with those paid by similar nations,” according to a White House news release.
Read MoreThere is no association between the COVID-19 vaccine and miscarriage, a new Obstetrics and Gynecology study confirms.
Read MoreTwo Phase III trials in patients with uncontrolled asthma found Breztri Aerosphere met all primary endpoints, demonstrating a statistically significant and clinically meaningful improvement in lung function.
Read MoreStudy suggests the 2024 withdrawal of the asthma medication Flovent was linked to increases in children discontinuing inhaled steroid therapy.
Read MoreBrensocatib significantly reduced the rate of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis compared to placebo.
Read MoreThe Consumer Product Safety Commission will stop collecting data on injuries from adverse drug effects and other incidents like car accidents, according to a report from Reuters.
Read MoreRepeated antibiotic use before age 2 is associated with a higher risk for asthma, food allergies and hay fever later in life.
Read MoreThe United States prevented far more in medical spending and lost-productivity than it spent on testing, buying and delivering the COVID-19 vaccines.
Read MoreIn laboratory testing, new drug candidate Jun13296 remained effective against Paxlovid-resistant strains of the coronavirus SARS-CoV-2.
Read MoreResearchers have developed a universal vaccine that targets coronaviruses and the sugars that they use as cover.
Read MoreTwo FDA–approved flu antivirals did not successfully treat severe H5N1 infections, and route of infection (eye, nose or mouth) significantly impacted effectiveness.
Read MoreThe FDA convened an interagency panel to comprise its recommendations for the 2025-2026 flu vaccine composition.
Read MoreOmlyclo (omalizumab-igec) is the first and only biosimilar designated as interchangeable with Xolair (omalizumab) for the treatment of moderate to severe persistent asthma, CRSwNP, IgE-mediated food allergy, and chronic spontaneous urticaria.
Read MoreTezspire, an add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma, showed significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in a Phase 3 clinical trial.
Read MoreXolair was superior to oral immunotherapy in both effectiveness and fewer side effects for people with one or more food allergies.
Read MoreA scheduled meeting of the US FDA’s influenza vaccine advisory board set for March 13 has been canceled, following another postponement by the CDC last week.
Read More